Missouri bills · 2026 Regular Session
Missouri SB 1219
Modifies provisions relating to distributors of hypodermic needles
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Patty Lewis (Democratic)
Summary
Official abstract published by the Missouri legislature· abstract
SB 1219 - Under this act, any entity registered with the Department of Health and Senior Services that possesses, distributes, or delivers hypodermic needles or syringes for the purposes of operating a syringe exchange program or otherwise mitigating health risks associated with unsterile injection drug use shall be exempt from the offense of unlawful distribution, delivery, or sale of drug paraphernalia, if such entity is not located within 500 feet of a school building, as well as the offense of unlawful manufacturing with intent to deliver drug paraphernalia.
This act is identical to SB 472 (2025), SB 997 (2024), SB 623 (2023), provisions in CCS/HCS/SS/SB 690 (2022), and CCS#2/HCS/SS/SB 64 (2021), substantially similar to HB 1486 (2020), SB 668 (2020), HCS/SS/SB 580 (2020), and HCS/HB 168 (2019), and similar to SCS/HB 1620 (2019).
SARAH HASKINS
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Dec 1, 2025 · Senate
Prefiled - Jan 7, 2026 · Senate
S First Read - Jan 27, 2026 · Senate
Second Read and Referred S Families, Seniors and Health Committee